SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-22-000014
Filing Date
2022-08-05
Accepted
2022-08-04 21:35:53
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-20220630.htm   iXBRL 10-Q 1378381
2 EX-10.1 nktr2022-06x30xexx101ar201.htm EX-10.1 140792
3 EX-10.2 nktr2022-06x30xexx102north.htm EX-10.2 95076
4 EX-31.1 nktr2022-06x30xexx311.htm EX-31.1 9510
5 EX-31.2 nktr2022-06x30xexx312.htm EX-31.2 9636
6 EX-32.1 nktr2022-06x30xexx321.htm EX-32.1 5831
12 image_0a.jpg GRAPHIC 106542
  Complete submission text file 0000906709-22-000014.txt   6111495

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20220630.xsd EX-101.SCH 43191
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20220630_cal.xml EX-101.CAL 65493
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20220630_def.xml EX-101.DEF 175487
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20220630_lab.xml EX-101.LAB 465603
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20220630_pre.xml EX-101.PRE 295832
58 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20220630_htm.xml XML 891390
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 221138386
SIC: 2834 Pharmaceutical Preparations